Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-11 of 11 for your search:
Drug:
acetylsalicylic acid
Find trials that include:
Any drugs shown
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase III Randomized Chemoprevention Study of Esomeprazole With Versus Without Acetylsalicyclic Acid (Aspirin) in Preventing Esophageal Cancer in Patients With Barrett's Metaplasia
Phase:
Phase III
Type:
Biomarker/Laboratory analysis, Prevention
Status:
Active
Age:
18 and over
Sponsor:
Other, Pharmaceutical / Industry
Protocol IDs:
OCTO-ASPECT
, RADCLIFFE-32, ZENECA-RADCLIFFE-32, EUDRACT-2004-003836-77, ISRCTN85156844, EU-20628, NCT00357682
2.
Chemoprevention of Colorectal Adenomas
Phase:
Phase III
Type:
Prevention
Status:
Active
Age:
40 to 75
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
COLO CP-01-US
, NCT00486512
3.
Phase III Randomized Study of Acetylsalicylic Acid (Aspirin) in Patients With Completely Resected Dukes Stage C Colon or Rectal Cancer, Dukes Stage B Rectal Cancer, or High-Risk Dukes Stage B Colon Cancer
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
21 and over
Sponsor:
Other
Protocol IDs:
SINGAPORE-ICR-02
, ICR-02, SINGAPORE-ASCOLT, NCT00565708, SINGAPORE-07-32-LGI
4.
A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer Patients
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
05-0427
, NCT00263211
5.
Phase II Randomized Chemoprevention Study of Esomeprazole Magnesium With Versus Without Acetylsalicylic Acid (Aspirin) in Patients With Barrett Esophagus
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Prevention
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
MAYO-MAY04-4-01
, MAY04-4-01, NCT00474903
6.
A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
RV-PI-0103
, 07/04, NCT00482261
7.
Trial of Aspirin and Arginine Restriction in Colon Cancer
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 to 80
Sponsor:
Other
Protocol IDs:
UCI 07-47
, NCT00578721
8.
Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
2007-0266
, NCT00790452
9.
Phase II Randomized Chemoprevention Study of Acetylsalicylic Acid (Aspirin) in Patients at Increased Risk for the Development or Recurrence of Colorectal Cancer
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Prevention
Status:
Active
Age:
Under 75
Sponsor:
NCI
Protocol IDs:
NU-NWU04-2-03
, NWU04-2-03, NCT00468910
10.
Effects of ASA on Prostate Tissue
Phase:
No phase specified
Type:
Prevention
Status:
Active
Age:
45 to 74
Sponsor:
Other
Protocol IDs:
05-7956-01
, NCT00234299
11.
The Effect of Aspirin on Angiogenesis Proteins in Women on Tamoxifen Therapy
Phase:
No phase specified
Type:
Treatment
Status:
Active
Age:
18 to 95
Sponsor:
Other
Protocol IDs:
V0801
, NCT00727948
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute